{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:16:54Z","timestamp":1770819414470,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hubei Province Health and Family Planning Scientific Research Project","award":["WJ2018H206"],"award-info":[{"award-number":["WJ2018H206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10863-020-09824-w","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T17:02:26Z","timestamp":1581181346000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimalarial drug artesunate is effective against chemoresistant anaplastic thyroid carcinoma via targeting mitochondrial metabolism"],"prefix":"10.1007","volume":"52","author":[{"given":"Ling","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-9739","authenticated-orcid":false,"given":"Honghua","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"9824_CR1","doi-asserted-by":"publisher","first-page":"ed50","DOI":"10.3332\/ecancer.2015.ed50","volume":"9","author":"Y Augustin","year":"2015","unstructured":"Augustin Y, Krishna S, Kumar D, Pantziarka P (2015) The wisdom of crowds and the repurposing of artesunate as an anticancer drug. Ecancermedicalscience 9:ed50","journal-title":"Ecancermedicalscience"},{"key":"9824_CR2","doi-asserted-by":"crossref","unstructured":"Berte N, Lokan S, Eich M, Kim E, Kaina B (2016) Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence. Oncotarget 7:67235\u201367250","DOI":"10.18632\/oncotarget.11972"},{"key":"9824_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JOP.2016.012013","volume":"12","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, Zafereo M, Gunn GB, Ferrarotto R (2016) Anaplastic thyroid carcinoma: treatment in the age of molecular targeted therapy. J Oncol Pract\/Am Soc Clin Oncol 12:511\u2013518","journal-title":"J Oncol Pract\/Am Soc Clin Oncol"},{"key":"9824_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbabio.2006.05.019","volume":"1757","author":"P Cassano","year":"2006","unstructured":"Cassano P, Sciancalepore AG, Pesce V, Fluck M, Hoppeler H, Calvani M, Mosconi L, Cantatore P, Gadaleta MN (2006) Acetyl-L-carnitine feeding to unloaded rats triggers in soleus muscle the coordinated expression of genes involved in mitochondrial biogenesis. Biochim Biophys Acta 1757:1421\u20131428","journal-title":"Biochim Biophys Acta"},{"key":"9824_CR5","doi-asserted-by":"publisher","first-page":"87623","DOI":"10.18632\/oncotarget.21007","volume":"8","author":"MC de Padua","year":"2017","unstructured":"de Padua MC, Delodi G, Vucetic M, Durivault J, Vial V, Bayer P, Noleto GR, Mazure NM, Zdralevic M, Pouyssegur J (2017) Disrupting glucose-6-phosphate isomerase fully suppresses the \u201cWarburg effect\u201d and activates OXPHOS with minimal impact on tumor growth except in hypoxia. Oncotarget 8:87623\u201387637","journal-title":"Oncotarget"},{"key":"9824_CR6","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","volume":"68","author":"R Dell'Eva","year":"2004","unstructured":"Dell'Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68:2359\u20132366","journal-title":"Biochem Pharmacol"},{"key":"9824_CR7","first-page":"200","volume":"26","author":"HY Dong","year":"2014","unstructured":"Dong HY, Wang ZF (2014) Antitumor effects of artesunate on human breast carcinoma MCF-7 cells and IGF-IR expression in nude mice xenografts. Chin J Cancer Res 26:200\u2013207","journal-title":"Chin J Cancer Res"},{"key":"9824_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","volume":"65","author":"JH Du","year":"2010","unstructured":"Du JH, Zhang HD, Ma ZJ, Ji KM (2010) Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother Pharmacol 65:895\u2013902","journal-title":"Cancer Chemother Pharmacol"},{"key":"9824_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","volume":"13","author":"T Efferth","year":"2007","unstructured":"Efferth T, Li PC, Konkimalla VS, Kaina B (2007a) From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13:353\u2013361","journal-title":"Trends Mol Med"},{"key":"9824_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000693","volume":"2","author":"T Efferth","year":"2007","unstructured":"Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M (2007b) Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2:e693","journal-title":"PLoS One"},{"key":"9824_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/AAC.03663-14","volume":"59","author":"AM Gopalakrishnan","year":"2015","unstructured":"Gopalakrishnan AM, Kumar N (2015) Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species. Antimicrob Agents Chemother 59:317\u2013325","journal-title":"Antimicrob Agents Chemother"},{"key":"9824_CR12","doi-asserted-by":"crossref","unstructured":"Greenshields AL, Shepherd TG, Hoskin DW (2017) Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol Carcinog 56:75\u201393","DOI":"10.1002\/mc.22474"},{"key":"9824_CR13","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","volume":"286","author":"A Hamacher-Brady","year":"2011","unstructured":"Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R, Brady NR (2011) Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem 286:6587\u20136601","journal-title":"J Biol Chem"},{"key":"9824_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho WE, Peh HY, Chan TK, Wong WS (2014) Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142:126\u2013139","journal-title":"Pharmacol Ther"},{"key":"9824_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejh.12176","volume":"91","author":"T Holien","year":"2013","unstructured":"Holien T, Olsen OE, Misund K, Hella H, Waage A, Ro TB, Sundan A (2013) Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate. Eur J Haematol 91:339\u2013346","journal-title":"Eur J Haematol"},{"key":"9824_CR16","first-page":"44","volume":"4","author":"XM Keutgen","year":"2015","unstructured":"Keutgen XM, Sadowski SM, Kebebew E (2015) Management of anaplastic thyroid cancer. Gland Surg 4:44\u201351","journal-title":"Gland Surg"},{"key":"9824_CR17","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.18632\/oncotarget.3004","volume":"6","author":"C Kim","year":"2015","unstructured":"Kim C, Lee JH, Kim SH, Sethi G, Ahn KS (2015) Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model. Oncotarget 6:4020\u20134035","journal-title":"Oncotarget"},{"key":"9824_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049\u20131055","journal-title":"Science"},{"key":"9824_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrc1836","volume":"6","author":"T Kondo","year":"2006","unstructured":"Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292\u2013306","journal-title":"Nat Rev Cancer"},{"key":"9824_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ijc.22804","volume":"121","author":"LN Li","year":"2007","unstructured":"Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX (2007) Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway. Int J Cancer 121:1360\u20131365","journal-title":"Int J Cancer"},{"key":"9824_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","volume":"90","author":"S Li","year":"2009","unstructured":"Li S, Xue F, Cheng Z, Yang X, Wang S, Geng F, Pan L (2009) Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NFkappaB p65. Int J Hematol 90:513\u2013521","journal-title":"Int J Hematol"},{"key":"9824_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/fcp.12266","volume":"31","author":"Q Li","year":"2017","unstructured":"Li Q, Ni W, Deng Z, Liu M, She L, Xie Q (2017) Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt\/mTOR and inducing oxidative stress. Fund Clin Pharmacol 31:301\u2013310","journal-title":"Fund Clin Pharmacol"},{"key":"9824_CR23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbrc.2018.03.079","volume":"498","author":"L Ma","year":"2018","unstructured":"Ma L, Cheng Q (2018) Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. Biochem Biophys Res Commun 498:912\u2013917","journal-title":"Biochem Biophys Res Commun"},{"key":"9824_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1128\/MMBR.60.2.301-315.1996","volume":"60","author":"SR Meshnick","year":"1996","unstructured":"Meshnick SR, Taylor TE, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 60:301\u2013315","journal-title":"Microbiol Rev"},{"key":"9824_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita M, Gravel SP, Chenard V, Sikstrom K, Zheng L, Alain T, Gandin V, Avizonis D, Arguello M, Zakaria C, McLaughlan S, Nouet Y, Pause A, Pollak M, Gottlieb E, Larsson O, St-Pierre J, Topisirovic I, Sonenberg N (2013) mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab 18:698\u2013711","journal-title":"Cell Metab"},{"key":"9824_CR26","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.18632\/oncotarget.1847","volume":"5","author":"X Papanikolaou","year":"2014","unstructured":"Papanikolaou X, Johnson S, Garg T, Tian E, Tytarenko R, Zhang Q, Stein C, Barlogie B, Epstein J, Heuck C (2014) Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget 5:4118\u20134128","journal-title":"Oncotarget"},{"key":"9824_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5306\/wjco.v2.i3.150","volume":"2","author":"F Perri","year":"2011","unstructured":"Perri F, Lorenzo GD, Scarpati GD, Buonerba C (2011) Anaplastic thyroid carcinoma: a comprehensive review of current and future therapeutic options. World J Clin Oncol 2:150\u2013157","journal-title":"World J Clin Oncol"},{"key":"9824_CR28","doi-asserted-by":"publisher","first-page":"22229","DOI":"10.1073\/pnas.0912074106","volume":"106","author":"A Ramanathan","year":"2009","unstructured":"Ramanathan A, Schreiber SL (2009) Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A 106:22229\u201322232","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9824_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fendo.2012.00133","volume":"3","author":"M Saiselet","year":"2012","unstructured":"Saiselet M, Floor S, Tarabichi M, Dom G, Hebrant A, van Staveren WC, Maenhaut C (2012) Thyroid cancer cell lines: an overview. Front Endocrinol 3:133","journal-title":"Front Endocrinol"},{"key":"9824_CR30","doi-asserted-by":"crossref","unstructured":"Subedi A, Futamura Y, Nishi M, Ryo A, Watanabe N, Osada H (2016) High-throughput screening identifies artesunate as selective inhibitor of cancer stemness: involvement of mitochondrial metabolism. Biochem Biophys Res Commun 477:737\u2013742","DOI":"10.1016\/j.bbrc.2016.06.128"},{"key":"9824_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.bbrc.2018.11.182","volume":"508","author":"Y Sun","year":"2019","unstructured":"Sun Y, Xu H, Chen X, Li X, Luo B (2019) Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance. Biochem Biophys Res Commun 508:626\u2013632","journal-title":"Biochem Biophys Res Commun"},{"key":"9824_CR32","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3892\/ol.2016.5187","volume":"12","author":"X Tai","year":"2016","unstructured":"Tai X, Cai XB, Zhang Z, Wei R (2016) In vitro and in vivo inhibition of tumor cell viability by combined dihydroartemisinin and doxorubicin treatment, and the underlying mechanism. Oncol Lett 12:3701\u20133706","journal-title":"Oncol Lett"},{"key":"9824_CR33","first-page":"279","volume":"39","author":"O Thanaketpaisarn","year":"2011","unstructured":"Thanaketpaisarn O, Waiwut P, Sakurai H, Saiki I (2011) Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-kappaB and PI3K\/Akt signaling pathways. Int J Oncol 39:279\u2013285","journal-title":"Int J Oncol"},{"key":"9824_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1734-1140(13)71021-1","volume":"65","author":"GS Wu","year":"2013","unstructured":"Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L, Chen XP, Wang YT (2013) Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacological Reports : PR 65:453\u2013459","journal-title":"Pharmacological Reports : PR"},{"key":"9824_CR35","doi-asserted-by":"publisher","first-page":"15947","DOI":"10.1074\/jbc.RA118.004180","volume":"293","author":"M Zdralevic","year":"2018","unstructured":"Zdralevic M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G, Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouyssegur J, Kreutz M (2018) Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \u201cWarburg effect\u201d restricting tumor growth to oxidative metabolism. J Biol Chem 293:15947\u201315961","journal-title":"J Biol Chem"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-020-09824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10863-020-09824-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-020-09824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:49:04Z","timestamp":1722419344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10863-020-09824-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["9824"],"URL":"https:\/\/doi.org\/10.1007\/s10863-020-09824-w","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}